Guardant Health, Inc., a leading precision oncology company, announced that Blue Cross and Blue Shield of Louisiana now offers coverage for the Guardant Reveal...
Invitae, a leading medical genetics company, announced new research published in Nature describing the first use of the company's personalized cancer monitoring (PCM) platform to...
Many cancer patients show no symptoms at early stages and receive diagnoses at advanced stages, which can drastically attenuate treatment effectiveness and decrease their...
